Natco Pharma settles patent litigation with Onyx Therapeutics over anti cancer drug- Kyprolis Medical Dialogues Bureau1 Jun 2019 2:39 PM ISTNew Delhi: Natco Pharma Thursday said it has settled patent litigation with Onyx Therapeutics Inc in the US over a generic version of Kyprolis, an...
Natco Pharma settles patent litigation over generic version of anti-cancer drug Kyprolis Medical Dialogues Bureau30 May 2019 5:12 PM ISTKyprolis is the trade name for the generic drug Carfilzomib. The anti-cancer drug is a targeted therapy and is classified as a Proteasome Inhibitor....
Following opioid suits, family behind deadly OxyContin squabbles Medical Dialogues Bureau11 May 2019 9:00 AM ISTNEW YORK: A united front among members of the billionaire Sackler family behind painkiller OxyContin is showing signs of strain from litigation over...
Lupin posts Q3 loss of Rs 152 crore on litigation over Perindopril Farhat Nasim7 Feb 2019 2:23 PM ISTLupin had a net loss of 1.52 billion rupees compared to a profit of 2.22 billion rupees in the same quarter last year, the company said.Mumbai: A...
Bayer asks judge to limit evidence in another round up cancer trial Medical Dialogues Bureau24 Jan 2019 9:15 AM ISTBayer denies allegations that glyphosate causes cancer, saying decades of independent studies have shown the world's most widely-used weed killer to...
